Also trades as: OBD.L (LSE) · $vol 0M
OXBOF OTC
Oxford BioDynamics Plc
1W: +0.0%
1M: +12.5%
3M: -40.0%
YTD: +28.6%
1Y: -85.1%
3Y: -80.2%
$0.00
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$1M
+72.2% ▲
5Y CAGR: +19.1%
Gross Profit
$522K
+80.6% ▲
Operating Income
-$11M
+14.1% ▲
Net Income
-$11M
+3.6% ▲
EPS (Diluted)
$-0.01
+82.2% ▲
EBITDA
-$10M
+4.5% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $341K | $154K | $510K | $636K | $1M |
| YoY Growth | -25.2% | -54.8% | +231.2% | +24.7% | +72.2% |
| Cost of Revenue | $898K | $38K | $244K | $347K | $573K |
| Gross Profit | $341K | $116K | $266K | $289K | $522K |
| Gross Margin | 100.0% | 75.3% | 52.2% | 45.4% | 47.7% |
| R&D Expenses | $911K | $552K | $794K | $809K | $615K |
| SG&A Expenses | $6M | $7M | $9M | $4M | $4M |
| Operating Expenses | $8M | $9M | $10M | $13M | $12M |
| Operating Income | -$8M | -$9M | -$10M | -$13M | -$11M |
| Operating Margin | -2202.9% | -5585.1% | -1993.7% | -2027.4% | -1011.3% |
| Interest Expense | $114K | $195K | $213K | $225K | $422K |
| Income Before Tax | -$8M | -$8M | -$11M | -$12M | -$11M |
| Tax Expense | -$947K | -$857K | -$585K | -$389K | -$269K |
| Net Income | -$7M | -$7M | -$11M | -$12M | -$11M |
| Net Margin | -1959.5% | -4357.1% | -2122.7% | -1818.7% | -1018.5% |
| EPS (Diluted) | $-0.07 | $-0.07 | $-0.07 | $-0.04 | $-0.01 |
| EBITDA | -$6M | -$7M | -$10M | -$10M | -$10M |
| Shares Outstanding | 93M | 100M | 147M | 256M | 1.39B |